Alla studier
RekryteringOBSERVATIONELL

Fabry Disease Registry & Pregnancy Sub-registry

This study, called the Fabry Registry, is an international program that carefully watches the health of people living with Fabry disease. It's not a clinical trial testing new medicines; instead, it observes how the disease affects people, no matter what treatment they are receiving. The main goals are to learn more about Fabry disease, how it changes over time, and to help doctors develop better ways to care for patients. There's also a special part of the study for pregnant women with Fabry disease, called the Pregnancy Sub-registry, which tracks their health and their babies' health during and after pregnancy to understand the effects of Fabry disease and its treatments. In both parts, patients receive their usual care, and no experimental treatments are given.

Överblick

Status
Rekrytering
Sponsor
Genzyme, a Sanofi Company
Inskrivningsmål
9,000
Starta
31 Jul 2001
Beräknad slutförande
31 Jan 2034

Vad handlar denna studie om?

Imagine a big, ongoing medical record that helps doctors understand Fabry disease better. That's essentially what the Fabry Registry is. It's a worldwide program that collects information about people who have Fabry disease. The idea is to gather lots of details over time, like how the disease starts, how it changes in different people, and what treatments they receive. This helps medical experts see the bigger picture of Fabry disease, including how it affects women, and helps them figure out the best ways to care for patients.

This isn't a study where you'd be given a new, untested medicine. Instead, it's about observing and recording. You would continue to see your own doctor and receive the care they think is best for you. The information gathered from many patients helps researchers improve their understanding and guides doctors in making recommendations for patient care. It also helps check how safe and effective existing treatments, like Fabrazyme®, are in the long run.

There's also a special part called the Fabry Pregnancy Sub-registry. This is specifically for women with Fabry disease who are pregnant or have been pregnant. It collects details about their pregnancy, birth, and even the baby's health for up to three years after birth. This is very important for understanding how Fabry disease and its treatments might affect pregnancy and newborns. Like the main Registry, it's about observing, not about giving experimental treatments, and all care remains under your doctor's guidance.

Viktiga punkter

  • This is an observation study, not a drug trial.
  • It helps doctors understand Fabry disease better.
  • It includes a special part for pregnant women with Fabry disease.
  • You continue with your regular doctor and treatments.
  • Your health information is collected to improve future care.
  • Du kan sluta delta när som helst utan att det påverkar din medicinska vård.

Vem kan vara berättigad?

To join the main Fabry Registry, you must have a clear diagnosis of Fabry disease. This means your doctor has confirmed the diagnosis through specific tests, like checking for a particular enzyme activity or a gene change linked to Fabry disease.

If you're a woman with Fabry disease and are pregnant or have been pregnant, you might also be able to join the Fabry Pregnancy Sub-registry. To do so, you first need to be part of the main Fabry Registry.

Good news – there are no reasons that would prevent you from joining either part of this study once you meet the main requirements. All ages and both sexes are welcome in the main registry.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Har du en bekräftad diagnos av Fabrys sjukdom?
  2. Are you willing to share your routine medical information?
  3. If you are pregnant or have been pregnant, are you also in the main Fabry Registry?
  4. Are you willing for information about your pregnancy and/or baby to be tracked?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to take part in this study, you won't be given any new or experimental medications. Instead, your doctors will simply share information about your regular medical check-ups and treatments with the study. This means you'll continue to receive your usual care from your own doctor, just as you do now. The study is about collecting information from your routine visits, not adding extra tests or appointments specifically for the study.

If you join the Pregnancy Sub-registry, information about your medical history, your pregnancy (like how it's progressing), and the birth of your baby would be collected. If you agree, information about your baby's growth and health would also be collected until they are three years old. The total duration of your participation depends on how long you remain under care for Fabry disease and, for the pregnancy part, for up to three years after your baby is born.

Potentiella risker och fördelar

The main benefit of taking part is contributing to a better understanding of Fabry disease, which can help improve care for yourself and others in the future. As no experimental treatments are given, there are no additional medical risks beyond your usual care. The main involvement is sharing your health information. Your privacy is important, and steps are taken to protect your personal details. You are free to withdraw from the study at any time without it affecting your medical care.

Locations (284)

  • University Of Alabama Birmingham- Nephrology- Site Number : 840018
    Verifierat postnummer
    Birmingham, USA· Avslutad
  • University Of Alabama Birmingham- Nephrology- Site Number : 840073
    Verifierat postnummer
    Birmingham, USA· Rekrytering
  • Phoenix Children's Hospital- Site Number : 840003
    Verifierat postnummer
    Phoenix, USA· Rekrytering
  • University of Arizona- Site Number : 840015
    Verifierat postnummer
    Tucson, USA· Rekrytering
  • Arkansas Children's Hospital- Site Number : 840109
    Verifierat postnummer
    Little Rock, USA· Rekrytering
  • University of Arkansas for Medical Sciences- Site Number : 840113
    Verifierat postnummer
    Little Rock, USA· Rekrytering
  • Southern California Permanente Medical Group- Site Number : 840108
    Verifierat postnummer
    Los Angeles, USA· Rekrytering
  • Usc Health Sciences Center Dept Of Genetics- Site Number : 840082
    Verifierat postnummer
    Los Angeles, USA· Avslutad
  • University Of California Los Angeles- Site Number : 840088
    Verifierat postnummer
    Los Angeles, USA· Rekrytering
  • UCSF Benioff Children's Hospital - Oakland- Site Number : 840029
    Verifierat postnummer
    Oakland, USA· Avslutad
  • Children's Hospital of Orange County- Site Number : 840074
    Verifierat postnummer
    Orange, USA· Rekrytering
  • University of California Irvine Medical Center- Site Number : 840036
    Verifierat postnummer
    Orange, USA· Rekrytering

Vanliga frågor

Vad är Fabrys sjukdom?

Fabry disease is a rare genetic condition that can affect many parts of the body, causing a range of symptoms.

Kommer jag att få ny medicin i denna studie?

No, this study does not involve giving any new or experimental medicines. You will continue to receive the care your own doctor prescribes.

Varför är denna studie viktig?

It helps medical experts learn more about Fabry disease, how it affects people over time, and develop better ways to care for patients.

Hålls min personliga information privat?

Yes, your privacy is a priority. Steps are taken to protect your personal medical information.

Kan jag lämna studien när som helst?

Yes, you are free to stop participating in the study at any point, and your decision will not affect your medical care.

Hur du får reda på mer

Trial Transparency

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "Fabry Disease Registry & Pregnancy Sub-registry…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.